A novel nanogold-enhanced electrochemical impedance spectroscopy platform enables rapid, highly sensitive, and specific detection of Enterovirus 71, showing potential for point-of-care diagnostics.
Answers are grounded in this paper and cite their sources.
May enable rapid EV71 detection amid low titres; leaves open prospective validation before clinical adoption.
Enterovirus 71 (EV71) infection is an emerging infectious disease causing neurological complications and/or death within two to three days after the development of fever and rash. A low viral titre in clinical specimens makes the detection of EV71 difficult. Conventional approaches for detecting EV71 are time consuming, poorly sensitive, or complicated, and cannot be used effectively for clinical diagnosis. Furthermore, EV71 and Coxsackie virus A16 (CA16) may cross react in conventional assays. Therefore, a rapid, highly sensitive, specific, and user-friendly test is needed. We developed an EV71-specific nanogold-modified working electrode for electrochemical impedance spectroscopy in the detection of EV71. Our results show that EV71 can be distinguished from CA16, Herpes simplex virus, and lysozyme, with the modified nanogold electrode being able to detect EV71 in concentrations as low as 1 copy number/50 μl reaction volume, and the duration between sample preparation and detection being 11 min. This detection platform may have the potential for use in point-of-care diagnostics.
No takes yet. Share an insight, caveat, or question.
Li et al. (2013) studied Enterovirus 71 (EV71) infection. Nanogold-modified working electrode for electrochemical impedance spectroscopy vs. Coxsackie virus A16, Herpes simplex virus, and lysozyme was evaluated on Detection limit and specificity for EV71.
Synapse has enriched 10 related papers. Consider them for comparative context: